Loading...

Home
Stock
ITOS

ITOS News & Events

-

$

0.000

0.000(0.000%)1D

Overview Forecast Valuation Earnings News

Loading...

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Select market data provided by Financial Markets Infrastructure and Data|LSEG

Broker connection service provided by Connect to brokerage accounts for data and trading SnapTrade

Company

Home
Contact
About Us
News Release

Market

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

Strategies

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
CoinSwing
Daytrading Radar
Crypto Radar
Char Pattern Detection

Resource

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat with Tia
AI Screener
Backtesting Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Option Profit Calculator

Features

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
Whales Auto Tracker
Daytrading Center
Patterns Detection
Financial AI Agent
AI Screener
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Stock Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
Seeking Alpha

ITOS News

$HAREHOLDER NOTICE: M&A Class Action Firm Ongoing Investigation into the Merger of MTWO, ITOS, DYNX, and PHLT

Sep 05 2025Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and KLG on Behalf of Shareholders

Aug 20 2025PRnewswire

Investor Alert from Former Louisiana Attorney General: Kahn Swick & Foti, LLC Examines Price and Process in iTeos Therapeutics, Inc. Sale - ITOS

Aug 19 2025Globenewswire

Wells Fargo Maintains Equal-Weight on ITeos Therapeutics, Lowers Price Target to $11

Aug 07 2025Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, CORZ, ITOS, VBTX on Behalf of Shareholders

Aug 05 2025PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025

Jul 30 2025Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, VBTX, ITOS, WNS on Behalf of Shareholders

Jul 30 2025PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, SPTN on Behalf of Shareholders

Jul 30 2025Globenewswire

ITOS Events

Vor Bio Names Osovsky as General Counsel

Vor Bio (VOR) announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. Dr. Osovsky joins Vor Bio from iTeos Therapeutics (ITOS), where she served as Executive Vice President, Head of Legal & Corporate Secretary.

Vor Bio appoints Cumbo, Detheux to board of directors

Vor Bio (VOR) announced the appointment of Alexander Cumbo and Michel Detheux, Ph.D., to its Board of Directors, effective July 16, 2025. Alexander Cumbo currently serves as President and Chief Executive Officer of Solid Biosciences (SLDB). Michel Detheux, Ph.D., is President and Chief Executive Officer of iTeos Therapeutics (ITOS)

ITOS Monitor News

an image of No data

No data

ITOS Earnings Analysis

an image of undefined

People Also Watch